Medical 3D printing: a revolutionary technology… provided it’s used properly

Medical 3D printing is transforming the healthcare industry. Custom prosthetics, surgical guides, anatomical models, and personalized devices: the possibilities offered by additive manufacturing are immense and are paving the way for precision medicine!

Yet, despite this exceptional potential, many projects fail, go over budget, or fall significantly behind schedule. The cause? Technical or strategic errors that could have been avoided from the start. In the healthcare sector, where quality, patient safety, and regulatory compliance are paramount, every decision has direct consequences.

Lattice Services has identified the five most common mistakes and provides best practices to help you successfully complete your projects.

1. Choosing the wrong material

The choice of a material should never be based solely on its price or how easily it can be printed on a prototyping machine. In medical 3D printing, the material is the cornerstone of the device.

Depending on the clinical application, it is essential to consider:

• Biocompatibility: Will the material come into contact with the skin or mucous membranes, or will it be implanted? For how long?
• Mechanical strength: Can it withstand the physical stresses associated with its use?
• Sterilization: Can the material undergo autoclave, gamma radiation, or ethylene oxide (EtO) cycles without losing its properties?
• Dimensional stability and regulatory requirements.

Best practice: Clearly define the clinical environment, the type of patient contact, and the expected sterilization methods before even selecting the material or printing technology.

2. Neglecting the validation and quality control steps

Producing a visually successful printout is only the first step in the process. Before any device is used on a patient or even in clinical trials, a rigorous verification phase is essential.

Too many projects skip the rigorous characterization step by failing to verify:

• Geometric precision and adherence to tolerances.
• The absence of manufacturing residues (powders, cleaning solvents, supports).
• Consistent mechanical performance.

Without a validated validation protocol, the risk of device failure under real-world conditions increases.

The key approach: Integrate quality control and metrology processes from the design phase onward. Validation should be viewed as an integral part of the product lifecycle.

3. Confusing a prototype with the final product

This is a common source of confusion when moving from R&D to clinical use. A 3D-printed part that works perfectly in a bench-top test is not automatically a medical device ready for the market.

• A prototype is used to validate a concept, ergonomics, a geometric shape, or feasibility.
• The final product (the medical device) must meet much higher standards: consistent and documented quality, full traceability of material batches, and a technical dossier that complies with regulatory requirements.

The key approach: Clearly distinguish between the different stages of development. The equipment, material grades, and manufacturing environments (cleanrooms) for the final product are not the same as those used for rapid prototyping.

4. Underestimating the importance of repeatability

Producing a high-quality medical device once is one step, but it must be reproduced identically, in a standardized manner, over dozens or hundreds of manufacturing cycles.

In additive manufacturing, a multitude of variables directly influence the final result:

• The orientation of parts on the build plate.
• Temperature fluctuations and ambient humidity levels.
• Wear and tear on machine components.
• Manual post-processing steps.

Without controlling and stabilizing these variables, variations in quality from one batch to the next are inevitable!

The key approach: Standardize all standard operating procedures (SOPs), qualify equipment (IQ/OQ/PQ), and meticulously document every machine parameter to ensure a robust process.

5. Failing to properly plan for the industrialization phase

Many innovative projects are designed exclusively for the laboratory scale or for small-scale feasibility studies. However, as soon as the project expands and production volumes increase, new critical constraints arise:

• Production capacity and machine utilization rates.
• Scale-based cost model (materials, maintenance, post-processing labor).
• Delivery times and supply chain management.
• The burden of document management.

A printing technology that is ideal for producing two parts per week may prove to be economically and technically unfeasible for mass production.

The key approach: Adopt an industrial perspective from the very beginning of the project. Design the system with an eye toward production scalability and the requirements of the medical supply chain.

Medical 3D printing is a global process

By anticipating these five pitfalls early in the planning process, you can ensure the safety of your product development, reduce time to market, and guarantee the highest level of patient safety.